EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis

Lele Chang iD, Xuemei Zhang, Lei He, Qian Ma, Tianyuan Fang, Chengzhi Jiang, Zhigang Ma, Qingwei Li, Chunlong Wu, Ji Tao iD

The Oncologist · 2023

DOI: 10.1093/oncolo/oyad151 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Oncologist, 2023. Verfasst von Lele Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wu Jieping Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circulating tumor DNA (ctDNA) is increasingly used as a biomarker for metastatic rectal cancer and has recently shown promising results in the early detection of recurrence risk.

Methods

We conducted a systematic review and meta-analysis to explore the prognostic value of ctDNA detection in LARC patients undergoing neoadjuvant chemoradiotherapy (nCRT). We systematically searched electronic databases for observational or interventional studies that included LARC patients undergoing nCRT. Study selection according to the PRISMA guidelines and quality assessment of the REMARK tool for biomarker studies. The primary endpoint was the impact of ctDNA detection at different time points (baseline, post-nCRT, post-surgery) on relapse-free survival (RFS) and overall survival (OS). The secondary endpoint was to study the association between ctDNA detection and pathological complete response(pCR) at different time points.

Results

After further review and analysis of the 625 articles initially retrieved, we finally included 10 eligible studies. We found no significant correlation between ctDNA detection at baseline and long-term survival outcomes or the probability of achieving a pCR. However, the presence of ctDNA at post-nCRT was associated with worse RFS (HR = 9.16, 95% CI, 5.48-15.32), worse OS (HR = 8.49, 95% CI, 2.20-32.72), and worse pCR results (OR = 0.40, 95%CI, 0.18-0.89). The correlation between the presence of ctDNA at post-surgery and worse RFS was more obvious (HR = 14.94; 95% CI, 7.48-9.83).

Conclusions

Our results suggest that ctDNA detection is a promising biomarker for the evaluation of response and prognosis in LARC patients undergoing nCRT, which merits further evaluation in the following prospective trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyRectal NeoplasmsHumansPrognosisProspective StudiesChemoradiotherapyNeoplasm Recurrence, LocalBiomarkers, Tumor

Stichwörter der Autor:innen

circulating tumor DNAliquid biopsylocally advanced rectal cancerneoadjuvant chemoradiotherapyprognosissystematic review

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Department of Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Department of Endoscopic Room, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.

ORCID-Profile: Lele Chang, Ji Tao

Förderung

  • Wu Jieping Medical Foundation

Zitieren

APA

Chang, L., Zhang, X., He, L., Ma, Q., Fang, T., Jiang, C., Ma, Z., Li, Q., Wu, C., & Tao, J. (2023). Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis. The Oncologist. https://doi.org/10.1093/oncolo/oyad151

Vancouver

Chang L, Zhang X, He L, Ma Q, Fang T, Jiang C, et al. Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis. The Oncologist. 2023. doi:10.1093/oncolo/oyad151

BibTeX
@article{Chang2023,
  author = {Chang, Lele and Zhang, Xuemei and He, Lei and Ma, Qian and Fang, Tianyuan and Jiang, Chengzhi and Ma, Zhigang and Li, Qingwei and Wu, Chunlong and Tao, Ji},
  title = {Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis},
  journal = {The Oncologist},
  year = {2023},
  doi = {10.1093/oncolo/oyad151}
}
Kostenlos starten →